Jefferies analyst Dennis Ding maintained a Hold rating on Crinetics Pharmaceuticals (CRNX – Research Report) today and set a price target of ...
Analyst Justin Zelin of BTIG reiterated a Buy rating on Jasper Therapeutics (JSPR – Research Report), reducing the price target to $64.00.Stay ...
Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.
EV25 also has a window of efficacy of 96 hours postinfection, which is broader than the current standard of care. A research paper titled “Targeted recruitment of immune effector cells for rapid ...